ArticleRSC medicinal chemistry2026
Design and synthesis of carbazole-acrylamide-pyridinium hybrids as dual acetylcholinesterase/butyrylcholinesterase inhibitors and evaluation of their cytotoxic profile on SH-SY5Y and HEK293 cell lines.
Amir Mohammad Taherkhani, Halil Şenol, Yousef Valizadeh, Seyedeh Niloufar Ghafouri, Navid Dastyafteh, Aydın Aktaş, Nastaran Sadeghian, Fatemeh Moradkhani, Bagher Larijani, Mahmood Biglar and 3 more
Abstract read
In one paragraphArticle in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Amir Mohammad TaherkhaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Yousef ValizadehEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Seyedeh Niloufar GhafouriSchool of Chemistry, College of Science, University of Tehran Tehran Iran.
Navid DastyaftehCenter for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences Tehran Iran.
Nastaran SadeghianDepartment of Biotechnology, Faculty of Science, Bartin University Bartin Türkiye ptaslimi@bartin.edu.tr.
Fatemeh MoradkhaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Mahmood BiglarEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Maryam Mohammadi-KhanaposhtaniCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences Babol Iran maryammoha@gmail.com.ORCID https://orcid.org/0000-0001-7664-9664 Mohammad MahdaviEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
A novel series of seventeen carbazole-acrylamide-pyridinium-
Identifiers
PMID42824777
PMCPMC13629482
What OpenQuestion holds
Textmetadata
Read underepoch 390